Department of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Neuropharmacology. 2021 Mar 15;186:108476. doi: 10.1016/j.neuropharm.2021.108476. Epub 2021 Jan 30.
Pain is a complex experience with far-reaching organismal influences ranging from biological factors to those that are psychological and social. Such influences can serve as pain-related risk factors that represent susceptibilities to opioid use disorder. This review evaluates various pain-related risk factors to form a consensus on those that facilitate opioid abuse. Epidemiological findings represent a high degree of co-occurrence between chronic pain and opioid use disorder that is, in part, driven by an increase in the availability of opioid analgesics and the diversion of their use in a non-medical context. Brain imaging studies in individuals with chronic pain that use/abuse opioids suggest abuse-related mechanisms that are rooted within mesocorticolimbic processing. Preclinical studies suggest that pain states have a limited impact on increasing the rewarding effects of opioids. Indeed, many findings indicate a reduction in the rewarding and reinforcing effects of opioids during pain states. An increase in opioid use may be facilitated by an increase in the availability of opioids and a decrease in access to non-opioid reinforcers that require mobility or social interaction. Moreover, chronic pain and substance abuse conditions are known to impair cognitive function, resulting in deficits in attention and decision making that may promote opioid abuse. A better understanding of pain-related risk factors can improve our knowledge in the development of OUD in persons with pain conditions and can help identify appropriate treatment strategies. This article is part of the special issue on 'Vulnerabilities to Substance Abuse.'.
疼痛是一种复杂的体验,其影响范围广泛,涉及生物因素、心理因素和社会因素等。这些影响可能成为与疼痛相关的风险因素,代表了对阿片类药物使用障碍的易感性。本综述评估了各种与疼痛相关的风险因素,以就那些促进阿片类药物滥用的因素达成共识。流行病学研究结果表明,慢性疼痛和阿片类药物使用障碍之间存在高度的共同发生,部分原因是阿片类镇痛药的可获得性增加,以及它们在非医疗环境中的滥用。在使用/滥用阿片类药物的慢性疼痛患者的脑成像研究中,提示存在与滥用相关的机制,这些机制植根于中脑边缘皮质处理中。临床前研究表明,疼痛状态对增加阿片类药物的奖赏效应影响有限。事实上,许多研究结果表明,在疼痛状态下,阿片类药物的奖赏和强化作用会降低。阿片类药物使用的增加可能是由于阿片类药物的可获得性增加,以及对需要移动或社会互动的非阿片类强化物的可获得性降低所致。此外,慢性疼痛和物质滥用状况已知会损害认知功能,导致注意力和决策能力缺陷,从而可能促进阿片类药物滥用。更好地了解与疼痛相关的风险因素可以提高我们对疼痛患者中阿片类药物使用障碍发展的认识,并有助于确定适当的治疗策略。本文是“易患物质滥用”特刊的一部分。